Outset Medical (OM) Receivables (2019 - 2026)

Outset Medical (OM) has 8 years of Receivables data on file, last reported at $25.3 million in Q1 2026.

• Quarterly Receivables fell 31.36% year-over-year to $25.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.3 million (down 31.36% YoY) and the FY2025 annual result came in at $28.3 million, down 20.47% from the prior year.
• Receivables declined to $25.3 million in Q1 2026 per OM's latest filing, from $28.3 million in the prior quarter.
• Across five years, Receivables topped out at $36.9 million in Q2 2023 and bottomed at $22.5 million in Q3 2022.
• The 5-year median for Receivables is $34.1 million (2024), against an average of $31.8 million.
• The widest annual swing landed in 2022, when Receivables surged 122.12%; it then sank 31.36% in 2026.
• Tracing OM's Receivables over 5 years: stood at $28.1 million in 2022, then climbed by 17.49% to $33.0 million in 2023, then increased by 8.0% to $35.6 million in 2024, then decreased by 20.47% to $28.3 million in 2025, then fell by 10.61% to $25.3 million in 2026.
• Per Business Quant, the three latest OM Receivables figures stand at $25.3 million (Q1 2026), $28.3 million (Q4 2025), and $33.0 million (Q3 2025).

Peer Comparison